Literature DB >> 6807700

Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.

Y R Sharma, E Cotlier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6807700     DOI： 10.1016/s0014-4835(82)80019-5

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  4 in total

1.  Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor.

Authors:  Hong Zhang; Qiang Huang; Jing Zhai; Yi-ning Zhao; Li-ping Zhang; Yun-yun Chen; Ren-wei Zhang; Qing Li; Xiao-peng Hu
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

Review 2.  Clinical pharmacokinetics of sulindac. A dynamic old drug.

Authors:  N M Davies; M S Watson
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 3.  Pharmacological treatment strategies in age-related cataracts.

Authors:  J J Harding
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

4.  Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.

Authors:  M Bahgat; H H Anis; G A Peyman; H G Farahat; G J Parry; B Khoobehi
Journal:  Int Ophthalmol       Date:  1991-09       Impact factor: 2.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.